A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor-Reference-Cited by-同舟云学术

A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor

Published:2016-05 Issue:2 Volume:374 Page:229-240
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Niesen Judith,Hehmann-Titt Grit,Woitok Mira,Fendel Rolf,Barth Stefan,Fischer Rainer,Stein Christoph

Funder

RWTH-Aachen University

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference56 articles.

1. Immunotoxins: the role of the toxin;Antignani;Toxins,2013

2. Improving the therapeutic potential of human granzyme B for targeted cancer therapy;Hehmann-Titt;Antibodies,2013

3. Humanized immunotoxins: a new generation of immunotoxins for targeted cancer therapy;Mathew;Cancer Sci,2009

4. Fully human targeted cytotoxic fusion proteins: new anticancer agents on the horizon;Weidle;Cancer Genomics Proteomics,2012

5. Species-dependent functionality of the human cytolytic fusion proteins granzyme B-H22(scFv) and H22(scFv)-angiogenin in macrophages;Schiffer;Antibodies,2013

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling antibody drug conjugate potential using a granzyme B antibody fusion protein;BMC Biology;2024-03-14

2. Surface-anchored tumor microenvironment-responsive protein nanogel-platelet system for cytosolic delivery of therapeutic protein in the post-surgical cancer treatment;Acta Biomaterialia;2022-12

3. Expression and Purification of Human Granzyme B Fusion Protein to Induce Targeted Apoptosis in PSMA Positive Prostate Cancer Cells;Protein & Peptide Letters;2022-07

4. Antibody-Based Immunotoxins for Colorectal Cancer Therapy;Biomedicines;2021-11-19

5. Recombinant immunotoxins development for HER2-based targeted cancer therapies;Cancer Cell International;2021-09-06